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BACKGROUND	  
PRESENT	  STUDY	  
u  The	  HPV	  vaccine	  is	  recommended	  
for	  ages	  11-­‐12,	  but	  ages	  13-­‐26	  are	  
the	  catch-­‐up	  period.	  (Division	  of	  
STD	  Preven/on,	  2015)	  
u  College	  students	  age	  20-­‐24	  are	  
the	  most	  at	  risk	  for	  contrac#ng	  
HPV.	  (Miller,	  2002)	  
u  Women	  are	  about	  four	  #mes	  as	  
likely	  to	  pursue	  vaccina#on	  when	  
they	  perceive	  a	  recommenda#on	  






Strength	  of	  a	  provider’s	  
recommenda#on	  for	  the	  vaccine	  is	  
posi#vely	  correlated	  to	  perceived	  
quality	  of	  medical	  care.	  	  
HYPOTHESIS	  2	  
Perceived	  quality	  of	  medical	  care	  is	  
posi#vely	  correlated	  to	  willingness	  
to	  pursue	  vaccina#on.	  	  
RESEARCH	  QUESTION	  1	  
Do	  males	  and	  females	  understand	  
strength	  of	  recommenda#on	  in	  a	  
similar	  way?	  	  
HYPOTHESIS	  1	  
u  Significant	  posi#ve	  correla#on	  
between	  strength	  of	  recommenda#on	  
and	  PQMC	  
HYPOTHESIS	  2	  
u  Significant	  posi#ve	  correla#on	  
between	  PQMC	  and	  willingness	  to	  
pursue	  vaccina#on	  
RESEARCH	  QUESTION	  1	  
u  No	  significant	  difference	  between	  






N	  =	  126	  
98	  Female,	  28	  Male	  
MAge	  =	  22.11	  Years	  
Strength	  of	  Recommenda#on	  
Perceived	  Quality	  of	  Medical	  Care	  
Vaccine	  Recep#vity	  
Scenario	  1	  (strong):	  M	  =	  5.27	  
Scenario	  2	  (moderate):	  M	  =	  4.98	  
Scenario	  3	  (weak):	  M	  =	  4.86	  
u  Providers	  should	  focus	  on	  
improving	  pa#ents’	  PQMC	  as	  it	  is	  
similar	  to	  strength	  of	  
recommenda#on	  in	  increasing	  
willingness	  to	  pursue	  vaccina#on.	  
u  Future:	  Readdress	  defini#on	  of	  a	  
“Strong	  Recommenda#on”	  
LIMITATIONS	  
u  No	  significant	  difference	  was	  found	  
in	  perceived	  strength	  of	  
recommenda#on	  amongst	  provider	  
recommenda#on	  scenarios.	  	  
u  Further	  message	  tes#ng	  is	  needed.	  
